New Zealand Trial PSI-7977 and RBV With and Without PEG-IFN/recruiting link

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3


This study is currently recruiting participants.

Contacts and Locations


Please refer to this study by its ClinicalTrials.gov identifier: NCT01260350

Contacts

Contact: Fiona Mackay, BSc 6498171460 fiona.mackay@beltas.com

Contact: Robert Sorensen 609-613-4100 rsorensen@pharmasset.com  


Locations

New Zealand

Auckland Clinical Studies Ltd. Recruiting

Auckland, New Zealand

Contact: Ed Gane, Assoc. Prof

Principal Investigator: Ed Gane, Assoc. Prof

Christchurch Clinical Studies Trust Recruiting

Christchurch, New Zealand

Contact: Catherine Stedman, MD

Principal Investigator: Catherine Stedman, MD